Researchers from the Germans Trias i Pujol Research Institute (IGTP) have published a review analyzing the therapeutic ...

FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL Marks the start of the second Phase IIa trial to evaluate first-in-class monoclonal antibody CIT-013 this year, following the ...

Galderma opens up new chapter for Sculptra with MDR certification and new expanded indication for body: Zug, Switzerland Monday, December 8, 2025, 12:00 Hrs [IST] Galderma, the pu ...

Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, announced today the 20 November 2025 publication of a pre ...

Spinal Cord Injury (SCI) is a devastating neurological disorder that often leads to permanent neural dysfunction. Current treatments fail to address ...

The "Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Exosome Therapeutics Market, ...

An offshore trial has found a link between kidney malfunction and Alzheimer's, while a local biotech legend takes a different ...

Aethlon’s Hemopurifier is designed to bind and remove harmful EVs from blood through a combination of plasma separation, size exclusion, and binding to a proprietary affinity resin containing plant ...

The sunbird Syn (TM) assay accurately classified Parkinson's disease-positive blood samples with 81% accuracy through the direct detection of EV-bound aggregated alpha-synuclein proteins -- -- With no ...

Sweat is turning into one of medicine’s most revealing data streams, and artificial intelligence is learning how to read it.

QUT researchers have been successful in securing six National Industry PhD Program awards. They are:Associate Professor Brett ...

Research confirms creatine's safety, highlighting misinformation and low-quality supplements as primary concerns over cancer ...